Ellipses, RET

Ellipses' next generation selective RET inhibitor EP0031/ A400 cleared to start Phase 2

Veröffentlicht: 07.08.2025 um 18:08 Uhr, prnewswire.co.uk

Ellipses Pharma England United States of America United Kingdom China

View original content:https://www.prnewswire.co.uk/news-releases/ellipses-next-generation-selective-ret-inhibitor-ep0031a400-cleared-to-start-phase-2-302132037.html

en | boerse | 67928257 |